In October 2025, the Consortium released a Request for Proposals (RFP) for research proposals from investigators at the different Consortium member institutions.
The Consortium for Medical Marijuana Clinical Outcomes Research (Consortium) received 28 proposals in response to its 2026 Request for Proposals (RFP), submitted by investigators from different Consortium member institutions. These proposals were reviewed by ad-hoc out-of-state faculty reviewers with demonstrated expertise in the respective research area using NIH criteria for scientific review of research proposals. Funding recommendations were made after careful consideration of the merit of each proposal and its contribution to the consortium research mission by the Consortium board. The Consortium research mission per statute is to contribute to understanding the effects of medical marijuana use and to promote informed decisions regarding policy and clinical practice related to the treatment of debilitating medical conditions with marijuana.
Seven new awards along with one Level-2 renewals will be made in the 2026 cycle of the Medical Marijuana Clinical Outcomes Research Consortium Grants Program. Below is the list of proposal titles, principal investigators, and respective member institutions.
Examining the interplay between high genetic risk for psychosis and cannabis exposure
PI: Paola Giusti-Rodriguez, PhD
Mechanistic Mapping of the Neuro-Inflammatory Impact of Medical Marijuana on Older Adults with Chronic Pain in a Prospective Cohort
PI: Jennifer Hu, PhD
Role of cannabinoid-based therapeutics in the prophylaxis and treatment of Alzheimer's dementia
PI: Catherine Marcinkiewcz, PhD
Assessing Risks and Benefits of Medical Marijuana Formulations in a Rodent Model of PTSD
PI: Marek Schwendt, PhD
Advancing Nurse-led Cannabis Harm Reduction (ANCHOR)
PI: Renessa Williams, PhD
Impact of Medical Marijuana Use on IL-22–Mediated Mucosal Immunity and Microbiome Composition in Inflammatory Bowel Disease
PI: Mariola Ferraro, PhD
AI-Powered Analysis of Cannabis Use and Mental Health Outcomes: Age-Stratified Evidence from EHR Data
PI: Masoud Rouhizadeh, PhD
Evaluation of the Effects of Cannabis on the Glymphatic System and Sleep Quality in People with Multiple Sclerosis
PI: Teddy Salan, PhD
